technology
LONDON (Reuters) - The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday.
from Reuters: Technology News http://ift.tt/2t4am7E
via Blogger http://ift.tt/2uc7WT3
via Blogger http://ift.tt/2sutCN0
EmoticonEmoticon